Retooling spare parts: Gene duplication and cognition
Center for Autism Research and Treatment and the Program in Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California, USA.Nature Neuroscience (Impact Factor: 16.1). 01/2013; 16(1):6-8. DOI: 10.1038/nn.3292
Two new studies provide experimental evidence of how ancient genomic duplications of synaptic genes provided the substrate for diversification that ultimately expanded vertebrate cognitive complexity.
[Show abstract] [Hide abstract]
- "Identifying such links can be valuable in personalized medicine and will extend our knowledge of recognized cholinergic controllers. The recently discovered role of gene duplication events in cognition  behooves the exploration of common variations in the expanded family of cholinergic regulators for genetic risks of autism and other mental diseases . Also, de novo mutations in cholinergic regulators should be tested for impaired synaptic networks, as in schizophrenia , and the biogenesis of circular RNAs raises new questions in view of the involvement of changed circular RNA levels in controlling alternative splicing, which is essential for maintaining the cholinergic signaling process. "
ABSTRACT: A century after the discovery of acetylcholine (ACh), we recognize both ACh receptors, transporters, and synthesizing and degrading enzymes and regulators of their expression as contributors to cognition, metabolism, and immunity. Recent discoveries indicate that pre- and post-transcriptional ACh signaling controllers coordinate the identity, functioning, dynamics, and brain-to-body communication of cholinergic cells. Checks and balances including epigenetic mechanisms, alternative splicing, and miRNAs may all expand or limit the diversity of these cholinergic components by consistently performing genome-related surveillance. This regulatory network enables homeostatic maintenance of brain-to-body ACh signaling as well as reactions to nicotine, Alzheimer's disease anticholinesterase therapeutics, and agricultural pesticides. Here I review recent reports on the functional implications of these controllers of cholinergic signaling in and out of the brain. Copyright © 2015 Elsevier Ltd. All rights reserved.Trends in Neurosciences 06/2015; 38(7). DOI:10.1016/j.tins.2015.05.007 · 13.56 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Information gathered on the genomic organization of cholinesterase genes, advances in biochemical characterization of the various subunits and the elucidation of the tertiary structure of the T. californica enzyme can serve as a basis for a unified nomenclature in cholinesterase research. Herein are some recommendations for nomenclature of catalytic and structural subunits, for designation of cholinesterase gene exons and secondary structure motifs, and for numeration of amino acid positions.Multidisciplinary Approaches to Cholinesterase Functions, 01/1992: pages 285-288; , ISBN: 978-1-4613-6328-6
- [Show abstract] [Hide abstract]
ABSTRACT: The discovery of the first neurotransmitter — acetylcholine — was soon followed by the discovery of its hydrolysing enzyme, acetylcholinesterase. The role of acetylcholinesterase in terminating acetylcholine-mediated neurotransmission made it the focus of intense research for much of the past century. But the complexity of acetylcholinesterase gene regulation and recent evidence for some of the long-suspected 'non-classical' actions of this enzyme have more recently driven a profound revolution in acetylcholinesterase research. Although our understanding of the additional roles of acetylcholinesterase is incomplete, the time is ripe to summarize the evidence on a remarkable diversity of acetylcholinesterase functions.Nature reviews Neuroscience 05/2001; 2(4):294-302. DOI:10.1038/35067589 · 31.43 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.